XML 126 R43.htm IDEA: XBRL DOCUMENT
v3.20.4

Associated companies (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2020
Statement [line items] |
Schedule disclosing information related to associates |
|  | Net income statement effect |  | Other comprehensive income effect |  | Total comprehensive income effect |
(USD millions) |  | 2020 |  | 2019 |  | 2018 |  | 2020 |  | 2019 |  | 2018 1 |  | 2020 |  | 2019 |  | 2018 |
Roche Holding AG, Switzerland |  | 677 |  | 662 |  | 526 |  | – 56 |  | – 94 |  | 75 |  | 621 |  | 568 |  | 601 |
GlaxoSmithKline Consumer Healthcare Holdings Ltd., UK |  |  |  |  |  | 5 910 |  |  |  |  |  | – 557 |  |  |  |  |  | 5 353 |
Others |  | – 4 |  | – 3 |  | 2 |  |  |  |  |  |  |  | – 4 |  | – 3 |  | 2 |
Associated companies related to continuing operations |  | 673 |  | 659 |  | 6 438 |  | – 56 |  | – 94 |  | – 482 |  | 617 |  | 565 |  | 5 956 |
1 In 2018, Novartis share of other comprehensive income recognized by associated companies, net of taxes of USD 511 million was recycled into the consolidated income statement as a result of the divestment of the investment in GSK Consumer Healthcare Holdings Ltd. No Novartis share of other comprehensive income recognized by associated companies, net of taxes was recycled into the consolidated income statement in 2020 and 2019.
Schedule disclosing information related to associates, balance sheet value |
|  | Balance sheet value |
(USD millions) |  | December 31, 2020 |  | December 31, 2019 |
Roche Holding AG, Switzerland |  | 9 407 |  | 8 445 |
Others |  | 225 |  | 199 |
Total |  | 9 632 |  | 8 644 |
Roche Holding AG, Switzerland |
Statement [line items] |
Associates summarized financial information |
(CHF billions) |  | Current assets |  | Non-current assets |  | Current liabilities |  | Non-current liabilities |
December 31, 2019 |  | 31.3 |  | 56.4 |  | 24.1 |  | 23.1 |
June 30, 2020 |  | 27.7 |  | 55.7 |  | 22.5 |  | 23.1 |
(CHF billions) |  | Revenue |  | Net income |  | Other comprehen- sive income |  | Total comprehen- sive income |
December 31, 2019 |  | 63.8 |  | 12.3 |  | – 0.9 |  | 11.4 |
June 30, 2020 |  | 30.4 |  | 7.2 |  | – 0.7 |  | 6.5 |
Purchase price allocation associates |
(USD millions) |  | December 31, 2020 |
Novartis share of Roche’s estimated net assets |  | 2 585 |
Novartis share of reappraised intangible assets |  | 117 |
Implicit Novartis goodwill |  | 3 233 |
Current value of share in net identifiable assets and goodwill |  | 5 935 |
Accumulated equity accounting adjustments and translation effects less dividends received |  | 3 472 |
Balance sheet value |  | 9 407 |
Schedule disclosing information related to associates, net income effect |
(USD millions) |  | 2020 |  | 2019 |  | 2018 |
Novartis share of Roche's estimated current-year consolidated net income |  | 913 |  | 910 |  | 799 |
Prior-year adjustment |  | – 64 |  | – 129 |  | – 125 |
Amortization of fair value adjustments relating to intangible assets, net of taxes of USD 26 million (2019: USD 24 million; 2018: USD 40 million) |  | – 172 |  | – 162 |  | – 148 |
Partial release of deferred tax liability recognized |  |  |  | 43 |  |  |
Net income effect |  | 677 |  | 662 |  | 526 |
GlaxoSmithKline Consumer Healthcare Holdings Ltd., UK |
Statement [line items] |
Schedule disclosing information related to associates, net income effect |
(USD millions) |  | 2018 |
Novartis share of GSK Consumer Healthcare's estimated current-year consolidated net income |  | 119 |
Prior-year adjustment |  | 4 |
Amortization of fair value adjustments relating to intangible assets and inventory, net of taxes of USD 1 million |  | – 3 |
Pre-tax gain on divestment of GSK Consumer Healthcare |  | 5 790 |
Net income effect |  | 5 910 |

X
- Definition The disclosure of associates. [Refer: Associates [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2019-01-01 -Paragraph 17 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2019-en-r&anchor=para_17_b&doctype=Standard -URIDate 2019-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2019-01-01 -Paragraph 16 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2019-en-r&anchor=para_16_b&doctype=Standard -URIDate 2019-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2019-01-01 -Paragraph B4 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2019-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B -URIDate 2019-03-27 + Details
Name: | ifrs-full_DisclosureOfSignificantInvestmentsInAssociatesExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_AssociatesSummarizedFinancialInformationTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_DisclosureOfAssociatesBalanceSheetTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_DisclosureOfAssociatesNetIncomeEffectTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_PurchasePriceAllocationAssociatesTableTextBlock
Namespace Prefix: | nvs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | nvs_StatementLineItems
Namespace Prefix: | nvs_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_RocheHoldingAGMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SignificantInvestmentsInAssociatesAxis=nvs_GlaxoSmithKlineConsumerHealthcareHoldingsLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |